Resources Contact Us Home
Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety

Image Number 13 for United States Patent #8119616.

The present invention relates to a composition comprising an inclusion complex of a cyclodextrin and quinazoline containing zinc-binding moiety based derivatives. The cyclodextrin is preferable a .beta.-cyclodextrin or a derivative thereof. The quinazolines have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.

  Recently Added Patents
Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
Electrifying roller
Tread portion of an automobile tire
Method for isomerisation of hop alpha-acids using heterogeneous alkaline earth metal based catalysts
Encoding method and encoding device, decoding method and decoding device and transcoding method and transcoder for multi-object audio signals
Liquid crystal display
Establishing a graphical user interface (`GUI`) theme
  Randomly Featured Patents
Video coding apparatus which outputs a code string having a plurality of components which are arranged in a descending order of importance
Integrated circuit device and microcomputer
Front and side of a lamp
Carboxylic acid functional polyurethane polymers and blends thereof used in magnetic recording media
Development device and development method
Flexible column viscous spring damper
Packet switch and method thereof dependent on application content
Toy game apparatus
Synergistic pesticidal mixtures